Sign Up
OverviewAPI
Dyadic International, a global biotechnology company, has made progress towards commercializing animal-free recombinant serum albumin, positioning itself for growth in the global albumin market. The company will report its second-quarter financial results and host a corporate update conference call on August 9, 2023.

Ask a question